Vivor has a provider-facing technology platform that empowers providers to address financial toxicity by proactively identifying financial resources for their patients, said Ian Manner, MBA, co-founder, CEO, Vivor.
Vivor has a provider-facing technology platform that empowers providers to address financial toxicity by proactively identifying financial resources for their patients, said Ian Manners, MBA, co-founder, CEO, Vivor.
Transcript (slightly modified)
At Vivor, we make a provider-facing technology platform that really empowers providers to address financial toxicity by proactively identifying financial resources for their patients. So many patients out there, even though they have insurance, end up with a really unaffordable out-of-pocket cost; it could be a deductible, co-insurance, and so on. But, there’s a lot of resources out there that often go underused from pharmaceutical companies and from non-profit foundations. What Vivor’s done is we made it very easy for providers to match patients up with exactly the right set of resources without doing any research or any work. We integrate with their EHR, and so it really gives providers a very effective tool in their tool box to say, “We’re looking for solutions for financial toxicity, and we’re going to get you enrolled in these resources without you even having to think about it.”
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More